Skip to content

Clinical trials

Observational Autoimmune Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Observational Country / region: United States Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20033
20041
20053
20061
20072
20082
20095
20105
20116
20126
20134
20146
20151
20163
20172
20186
20202
202110
20223
20235
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Recruiting23
Terminated6
Enrolling by invitation5
Active, not recruiting3
Unknown status3
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)7
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)6
National Institute of Environmental Health Sciences (NIEHS)6
Duke University4
University of California, San Diego4
National Cancer Institute (NCI)3
National Institute of Dental and Craniofacial Research (NIDCR)3
iSpecimen Inc3
Columbia University2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases96
Arthritis, Rheumatoid14
Immune System Diseases11
Neoplasms11
Arthritis, Psoriatic9
Lupus Erythematosus, Systemic9
Multiple Sclerosis8
Psoriasis8
Crohn Disease7
Scleroderma, Diffuse7

Trials

Showing 1 to 25 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.